Global Optical Genome Mapping is Anticipated to Witness High Growth Owing to Increasing Adoption in

Author : Vedant B | Published On : 17 Apr 2024

Optical genome mapping is a genome mapping technique based on direct optical imaging of intact genomic DNA molecules. It allows researchers to visualize the whole genomes of organisms in a single experiment quickly and economically. Optical genome mapping provides structural insights into genomes that can be overlooked by DNA sequencing alone and it enables rapid screening for genomic variations. It helps in research related to human genetics, plant and animal genetics, cancer diagnostics and treatment and infectious disease research. The technique is mainly used to understand complex genomic rearrangements, detect structural variants, scaffold genome assembly, detect copy number variations and analyze karyotypes.

The Global Optical Genome Mapping Market is estimated to be valued at US$ 109.9 MN in 2024 and is expected to exhibit a CAGR of 21.% over the forecast period 2024 To 2031.

Key Takeaways:
Key players operating in the Global Optical Genome Mapping Market are Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio International Limited (Source BioScience), MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, and Cerba.

The growing demand for precision medicine and early disease diagnostics is fueling growth opportunities in the optical genome mapping market. Optical genome mapping is helping researchers develop personalized medicine strategies based on an individual's genomic structural variations. This is driving increased adoption of optical mapping technologies in clinical diagnostics and research labs globally.

The key players are expanding globally through agreements, acquisitions and collaborations to gain market shares. For instance, Bionano Genomics has collaborations with various research centers and hospitals across Europe, Asia and North America. Expansion to emerging markets will further support the market growth over the forecast period.

Market Drivers:

The increasing expenditure on research activities in human genetics and precision medicine is a major market driver. Optical mapping techniques are widely used in basic and translational research related to human genetics.
Rising incidences of genetic diseases and cancer globally is another key factor fueling the demand. Optical mapping helps in early diagnostics, disease risk assessment and developing targeted treatment options.

Market Restrains:
High installation and maintenance costs of optical mapping systems limits its adoption in small labs and research facilities.
Lack of skilled professionals required for advanced sample preparation and data analysis remains a major challenge.

Segment Analysis
The Global Optical Genome Mapping Market is currently dominated by the Cytogenomics sub-segment. This is because cytogenomics technology is proven and highly reliable. It has applications in finding karyotypic abnormalities, complex genomic rearrangements, chromosome structure variations and identifying the causes of genetic diseases.

The Microfluidics sub-segment is expected to witness the fastest growth over the forecast period. This is owing to the ability of microfluidic systems to automate genome mapping procedures. It helps in analysing genomic DNA samples in vitro and obtaining high resolution genome maps cost-effectively. This reduces manual intervention and risk of contamination.

Regional Analysis
North America currently holds the largest share in the Global Optical Genome Mapping Market and is expected to maintain its dominating position over the forecast period. This can be attributed to the high adoption of advanced technologies, well-established healthcare systems and considerable funding for genomic research activities in the region.

The Asia Pacific region is anticipated to witness the fastest growth during the forecast period. This growth can be credited to factors such as improving healthcare infrastructure, growing investments from key players and increasing awareness about genetic disorders and precision medicine among people in the emerging economies of China and India.

Get more insights on Global Optical Genome Mapping Market